Sequential use of clomiphene citrate and human menopausal gonadotropin for induction of ovulation.
Explore the source record for details and available documents.
Adult↗
Biomedical subjects
Y R Lien
Publications and source records attributed to Y R Lien.
Schedule to inject in vitro matured oocytes may increase pregnancy after intracytoplasmic sperm injection.
To ascertain the value of using immature oocytes in an intracytoplasmic sperm injection (ICSI) program, the authors designed a schedule, at 5 p.m. on day 1 (the day of oocyte retrieval) and at 8 a.m. and 2 p.m. on day 2, to recognize and inject the in vitro matured (IVM) oocytes. For the 1,166 oocytes retrieved in 107 ICSI cycles, 128 (11.0%) were at the stage of metaphase I (MI) and 113 (9.7%) at germinal vesicle. Routine ICSI for metaphase 11 oocytes was performed at 2 p.m. on day 1 (initial ICSI). In culture medium of human tubal fluid with 15% maternal serum, 85.1% (205/241) immature oocytes progressed to maturation in which 16.4% (21/128) of MI oocytes matured at 5 p.m. of day 1. The rate of normal fertilization for IVM oocytes (58.5%) was not significantly different from that of initial ICSI (64.0%). One patient received a transfer of two fertilized IVM oocytes alone that were injected at 5 p.m. of day 1, maturing from the MI stage, and achieved a normal pregnancy. The fertilized IVM oocytes were replaced along with the embryos from initial ICSI for 40 cycles that led to 14 (35%) clinical pregnancies. In 43 fertilized IVM oocytes donated for research, we observed that cleavage (95.3%) to the 2- to 4-cell stage was not distinct from that of initial ICSI (94.6%); however, the percentage of embryos of grade I and II morphology was significantly smaller (24.4% vs. 62.5%). Only five (11.6%) developed to blastocysts in vitro. Twenty-one fertilized IVM oocytes were frozen for future transfer. A schedule to inject IVM oocytes in ICSI cycles may generate more accessible embryos for fresh transfer or cryopreservation to increase the chance of pregnancy, although the embryo quality was relatively poor.
Adult↗
Acrosin activity of human sperm did not correlate with IVF.
To evaluate the predicting value of sperm acrosin activity in human, the acrosin activity index (AAI) was measured in 95 semen samples from patients participating in an IVF program. All patients had at least two mature oocytes. Of 95 patients, 84 had successful fertilization and 11 failed to fertilize all oocytes in vitro. The numbers of mature oocytes were similar between fertilization and nonfertilization groups. The mean AAI, measured using a commercially available (Accu-Sperm) acrosin activity assay, was greater in the fertilization group than in the nonfertilization group, but the difference was not significant. There was no correlation between AAI and the in vitro fertilization rate of mature oocytes. The relation between AAI and semen parameters also showed no significant difference. It would appear that measurement of AAI inaccurately reflects in vitro fertilizability of human sperm.
Acrosin↗
First-trimester selective termination in multiple gestation by transvaginal ultrasound-guided intrathoracic injection of potassium chloride.
PATIENTS AND METHODS: Selective termination by transvaginal ultrasound-guided intrathoracic injection of potassium chloride (KC1) was performed between 8 and 10 weeks' gestation in eight women with multiple gestation after ovulation induction (6/8) or in vitro fertilization (IVF) (2/8). RESULTS: Four patients have delivered uneventfully at term, one delivered prematurely at 34 weeks' gestation with good neonatal outcome, and the other 3 patients lead a smooth pregnancy at present. No pregnancy loss or any major complication was found. CONCLUSIONS: Transvaginal ultrasound-guided intrathoracic injection of KC1 may be the procedure of choice for first-trimester selective termination with acceptable safety. However, more experience is needed to clarify the risk/benefit ratio associated with this procedure.
Abortion, Induced↗